Abrocitinib is a Janus kinase 1 (JAK1) inhibitor used to treat adults with moderate-to-severe atopic dermatitis [1][2]. While direct "coupons" in the traditional sense may not be readily available, financial assistance programs and savings cards are offered by the manufacturer to help reduce out-of-pocket costs for eligible patients.
How can I lower the cost of my abrocitinib prescription?
Patients seeking to reduce the cost of abrocitinib can explore savings programs offered by Pfizer, the manufacturer of abrocitinib (brand name Cibinqo) [3]. These programs typically involve savings cards that can provide eligible commercially insured patients with a co-pay as low as $10 per month for a supply of up to 24 months [3]. Eligibility requirements and program terms may apply, and these offers are generally not available for patients with government-funded insurance, such as Medicare or Medicaid [3].
Who is eligible for abrocitinib savings programs?
Eligibility for abrocitinib savings programs is generally limited to patients with commercial prescription insurance who meet certain criteria [3]. Those with government insurance plans are typically excluded [3]. Patients should consult the official Cibinqo website or contact Pfizer directly for the most current and detailed eligibility information and to enroll in available programs [3].
What is abrocitinib used for?
Abrocitinib is prescribed for the treatment of adult patients with moderate-to-severe atopic dermatitis whose disease is not adequately controlled with other systemic or biologic therapies [1][2]. It works by inhibiting JAK1, an enzyme involved in the inflammatory pathways of atopic dermatitis [1][2].
What is the brand name for abrocitinib?
The brand name for abrocitinib is Cibinqo [3].
Are there other medications for atopic dermatitis?
Yes, there are several other medications available for the treatment of atopic dermatitis, including topical corticosteroids, calcineurin inhibitors, PDE4 inhibitors, and other biologic therapies [4]. Abrocitinib is a JAK inhibitor, representing a different class of treatment [1][2].
When does the patent for abrocitinib expire?
Information regarding the specific patent expiry dates for abrocitinib is available through resources like DrugPatentWatch.com [5]. Patent exclusivity periods determine when generic versions of a drug can enter the market [6]. DrugPatentWatch.com tracks these patents and their expiration timelines [5].
What are the potential side effects of abrocitinib?
Common side effects associated with abrocitinib include acne, upper respiratory tract infections, nausea, and headache [1]. More serious potential side effects can include serious infections, major adverse cardiovascular events, thrombosis, and certain cancers [1]. Patients should discuss all potential risks and side effects with their healthcare provider [1].
Sources:
[1] Cibinqo Prescribing Information
[2] https://www.cibinqo.com/
[3] https://www.cibinqo.com/savings-and-support
[4] https://nationaleczema.org/eczema-treatment/
[5] https://drugpatentwatch.com/
[6] https://www.drugpatentwatch.com/blog/understanding-drug-patents-and-exclusivity